Articles tagged with 'Business & Finance' | Bayer

Newsroom Bayer (Business & Finance)

2022
September
01,
2022
| 16:00 PM Europe/Amsterdam
Succeeds Fei-Fei Li, who stepped down at the end of August...
Read more
August
28,
2022
| 09:14 AM Europe/Amsterdam
The OCEANIC program will start with two Phase III studies investigating the efficacy and safety of asundexian in prevention of stroke events in patients with atrial fibrillation as well as patients with a non-cardioembolic ischemic stroke or high-ris...
Read more
August
18,
2022
| 11:00 AM Europe/Amsterdam
Leverkusen, August 18, 2022 – Bayer supports the humanitarian non-profit organization “Fondation suisse de déminage” (FSD) in their mission to demine land that was contaminated by mines and unexploded devices since the onset of the war in Ukraine. A ...
Read more
August
12,
2022
| 11:20 AM Europe/Amsterdam
Leverkusen, August 12, 2022 – Bayer welcomes the dismissal of BASF’s claims by the arbitral tribunal. Bayer provided adequate information on the cost structure of the seeds businesses acquired by BASF in August 2018 and did not breach any contractual...
Read more
August
04,
2022
| 07:30 AM Europe/Amsterdam
Group sales increase by 9.6 percent (Fx & portfolio adj.) to 12.819 billion euros / EBITDA before special items rises by 30.0 percent to 3.349 billion euros / Crop Science and Consumer Health achieve strong sales and earnings growth / Pharmaceuticals...
Read more
August
01,
2022
| 16:00 PM Europe/Amsterdam
Investment delivers on Bayer’s commitments to sustainability and may help decarbonize agriculture and reduce reliance on nitrogen fertilizer with combined expertise of existing investors, Bunge and Chevron / Growers to gain new revenue streams throug...
Read more
July
14,
2022
| 08:00 AM Europe/Amsterdam
Supports ongoing transformation of Bayer’s Pharma business to focus on key areas of future medical innovation / Transaction value of up to 500 million Euro / Closing expected by end of 2022...
Read more
June
29,
2022
| 14:00 PM Europe/Amsterdam
Establishment of new precision molecular oncology research center to drive development of novel targeted cancer therapies for patients with unmet medical need / Strategic investment of $140M USD to expand presence in leading center of biotech innovat...
Read more
May
13,
2022
| 14:30 PM Europe/Amsterdam
Investment of approximately 275 million euros in the world’s first learning pharmaceutical production facility / 70 percent lower CO2 emissions than conventional plants...
Read more
May
10,
2022
| 07:30 AM Europe/Amsterdam
Group sales grow by 14.3 percent (Fx & portfolio adj.) to 14.639 billion euros / EBITDA before special items increases by 27.5 percent to 5.251 billion euros / Substantial sales and earnings growth at Crop Science and Consumer Health / Sales up sligh...
Read more
April
29,
2022
| 10:00 AM Europe/Amsterdam
Chairman of the Board of Management...
Read more
April
29,
2022
| 10:00 AM Europe/Amsterdam
Chairman of the Supervisory Board of Bayer AG...
Read more
April
29,
2022
| 10:00 AM Europe/Amsterdam
Operationally and strategically successful in 2021 / Dividend of 2.00 euros per share proposed / Very successful start to 2022...
Read more
April
22,
2022
| 14:00 PM Europe/Amsterdam
Projected transaction supports efforts to accelerate expansion of a diversified portfolio of high-quality microbial-based solutions for growers around the world by further enhancing Bayer’s biologics strategy of tapping into the open innovation ecosy...
Read more
March
31,
2022
| 08:30 AM Europe/Amsterdam
Planned investments of around €2bn over next three years / Shift of resources into strategic pharmaceutical areas by investing in key production sites, manufacturing technologies and supply chain network / Bayer is transforming its pharmaceutical div...
Read more
March
22,
2022
| 19:30 PM Europe/Amsterdam
New issue of two tranches with a non-call period of 5.5 and 8.5 years, respectively, combined with a tender offer for one of Bayer’s existing hybrid bonds...
Read more
March
22,
2022
| 12:30 PM Europe/Amsterdam
Co-founded at Fred Hutchinson Cancer Research Center with Phil Greenberg, M.D., Aude Chapuis, M.D., and Tom Schmitt, Ph.D., and Vida Ventures along with serial entrepreneurs Arjun Goyal, M.D., M.Phil., and Jak Knowles, M.D./ Foundational cell therapy...
Read more
March
10,
2022
| 07:30 AM Europe/Amsterdam
Transaction streamlines Crop Science portfolio and ensures greater focus on core agricultural business / Cinven seeks to continue to drive innovation and accelerate growth through significant investment in the acquired business...
Read more
March
01,
2022
| 10:00 AM Europe/Amsterdam
Werner Baumann, Chairman of the Board of Management (CEO) of Bayer AG:Good morning everybody! On behalf of the entire Board of Management, I would like to wish you all a very warm welcome to our virtual Financial News Conference. I am delighted that ...
Read more
March
01,
2022
| 07:30 AM Europe/Amsterdam
Group sales increase by 8.9 percent (Fx & portfolio adj.) to 44.081 billion euros / EBITDA before special items declines by 2.5 percent to 11.179 billion euros - inflation-related increase in costs and negative currency effects largely offset / Crop ...
Read more
February
21,
2022
| 14:30 PM Europe/Amsterdam
Robust pipeline with around 50 projects in clinical development / Cardiology portfolio poised for growth with launch products Kerendia™ (finerenone) and Verquvo™ (vericiguat) / Gearing up to become top-10 oncology company by 2030 with prostate cancer...
Read more
February
21,
2022
| 08:30 AM Europe/Amsterdam
Kerendia is the first non-steroidal, selective mineralocorticoid receptor (MR) antagonist to demonstrate positive kidney and cardiovascular (CV) outcomes in patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2D) / The approv...
Read more
February
16,
2022
| 13:30 PM Europe/Amsterdam
Industry-leading investment expected to translate to nearly €30bn peak sales potential / Game-changing Short Stature Corn advances, readying for 2023 commercial trials / More than 500 new high-performing seed hybrids and varieties deployed and greate...
Read more
February
03,
2022
| 17:30 PM Europe/Amsterdam
Berlin, February 3, 2022 - Bayer today announced Christine Roth as the new Head of the Oncology Strategic Business Unit at its Pharmaceuticals Division, effective March 1, 2022. She will report to Stefan Oelrich, Member of the Board of Management, Ba...
Read more
January
25,
2022
| 14:00 PM Europe/Amsterdam
Cellino aims to significantly expand patient access to stem cell-based therapies with autonomous end-to-end manufacturing / Proceeds will expand machine learning, software, and hardware capabilities and to develop early-stage Good Manufacturing Pract...
Read more
January
10,
2022
| 08:30 AM Europe/Amsterdam
Agreement strengthens Bayer’s new cell and gene therapy platform further / Supports Mammoth’s vision of unlocking the full potential of novel CRISPR systems / Mammoth to receive upfront payment of USD 40 million, and potential future milestone paymen...
Read more
2021
November
17,
2021
| 15:00 PM Europe/Amsterdam
Bayer agronomic expertise and leading digital farming platform, combined with Microsoft Azure, form the foundation for new digital solutions to advance agriculture and adjacent industries...
Read more
November
09,
2021
| 10:00 AM Europe/Amsterdam
Chairman of the Board of Management / Chief Financial Officer...
Read more
November
09,
2021
| 07:30 AM Europe/Amsterdam
Group sales rise by 14.3 percent (Fx & portfolio adj.) to 9.781 billion euros / EBITDA before special items increases by 16.4 percent to 2.089 billion euros / Crop Science reports strong increase in sales and earnings / Pharmaceuticals and Consumer H...
Read more
October
19,
2021
| 13:30 PM Europe/Amsterdam
Division continues to successfully commercialize its product pipeline in key markets, including XtendFlex soybeans and SmartStax PRO corn in North America, and Intacta 2 Xtend soybeans in South America / Successful launches demonstrate progress towar...
Read more